As we welcome another year, I want to thank you for your support. It warms my heart every time I walk the wards and hospital to think of the supporters who make Chris O’Brien Lifehouse a place of hope.
Despite the challenges that have faced our community over the last two years, you have enabled extraordinary progress across many areas of Chris O’Brien Lifehouse. It is thanks to you that we can celebrate the achievements you will read about in this issue.
Chris O’Brien Lifehouse is still the leading oncology cancer trials centre in NSW and the largest provider of Phase 1 cancer clinical trials. In fact, where other institutions slowed their research initiatives, ours increased, moving us closer to our strategic goal to grow as a ‘clinical innovation hub’.
2021 also saw us implement the Meditech Expanse Patient Management System, the first in Australia, which will revolutionise the way patients and clinicians connect with their medical records and results.
There is so much to be proud of over the last year, especially considering how trying the pandemic has been on the community. I want to thank you all from the bottom of my heart for making the two most challenging years I’ve witnessed in this industry not only bearable, but inspiring.
Chief Executive Officer